TGA Approval

TAKHZYRO lanadelumab (rch) 300 mg/2 mL solution for injection pre-filled syringe (330280)

ARTG ID

330280

ARTG Name

TAKHZYRO lanadelumab (rch) 300 mg/2 mL solution for injection pre-filled syringe

Sponsor

Takeda Pharmaceuticals Australia Pty Ltd

ARTG Date

June 15, 2020

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

TAKEDA PHARMACEUTICALS AUSTRALIA PTY. LTD.

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-CMI-02062-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01119-1

Ingredient Name

lanadelumab

Empowering clinical research with data-driven insights and AI-powered tools.